Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NIN1 (RPN12) binding protein 1 homolog (NOB1) is an RNA-binding protein and endoribonuclease required for processing of 20S pre-rRNA precursor during ribosome biogenesis, specifically for the maturation and cleavage of 18S rRNA in the cytoplasm and formation of the 40S ribosomal subunit in eukaryotes. It may also play a role in mRNA degradation. NOB1 is not well-characterized as a drug target or clinical biomarker. It is associated with ribosome assembly pathways and related to disease mechanisms in Diamond-Blackfan anemia, but generally not regarded as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NIN1 (RPN12) binding protein 1 homolog (NOB1).